AH Elmaagacli

753 citations

15 papers · 531 indexed · h-index 13

Hematology top 2%
Genetics top 10%
Public Health, Environmental and Occupational Health
Epidemiology
Oncology

Co-authors: UW Schaefer DW Beelen Rudolf Trenschel Bertram Opalka Dietrich W. Beelen Michael Roggendorf S. Seeber Ullrich Graeven
Topics: Acute Myeloid Leukemia Research (7 papers)Hematopoietic Stem Cell Transplantation (6 papers)Chronic Myeloid Leukemia Treatments (6 papers)
Cited by: Hematology Genetics Rheumatology
Journals: Blood Leukemia Haematologica
Partner nations: Germany United Kingdom

In The Last Decade

AH Elmaagacli

15 papers receiving 520 citations

Peers

Countries citing papers authored by AH Elmaagacli

Since Specialization

Citations

This map shows the geographic impact of AH Elmaagacli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by AH Elmaagacli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites AH Elmaagacli more than expected).

Fields of papers citing papers by AH Elmaagacli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by AH Elmaagacli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by AH Elmaagacli. The network helps show where AH Elmaagacli may publish in the future.

Co-authorship network of co-authors of AH Elmaagacli

This figure shows the co-authorship network connecting the top 25 collaborators of AH Elmaagacli. A scholar is included among the top collaborators of AH Elmaagacli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with AH Elmaagacli. AH Elmaagacli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Dynamic International Prognostic Scoring System scores, pre-transplant therapy and chronic graft-versus-host disease determine outcome after allogeneic hematopoietic stem cell transplantation for myelofibrosis 2012 ·Haematologica ·Markus Ditschkowski,AH Elmaagacli,Rudolf Trenschel,Tanja Gromke,(unknown),Michael Koldehoff,Dietrich W. Beelen	38
2	Retrospective analysis of treosulfan-based conditioning in comparison with standard conditioning in patients with myelodysplastic syndrome 2010 ·Bone Marrow Transplantation ·Inken Hilgendorf,Daniel Wolff,Tanja Gromke,Rudolf Trenschel,AH Elmaagacli,Uwe Pichlmeier,Christian Junghanß,M. Freund,Dietrich W. Beelen,J. Casper	11
3	Myeloablative allogeneic hematopoietic stem cell transplantation in elderly patients 2005 ·Clinical Transplantation ·(unknown),AH Elmaagacli,Rudolf Trenschel,(unknown),Michael Koldehoff,DW Beelen	17
4	Caspofungin as second-line therapy for fever of unknown origin or invasive fungal infection following allogeneic stem cell transplantation 2005 ·Bone Marrow Transplantation ·Rudolf Trenschel,Markus Ditschkowski,AH Elmaagacli,Michael Koldehoff,H. Ottinger,Nina K. Steckel,M. Hlinka,Rudolf Peceny,(unknown),(unknown),Dietrich W. Beelen	22
5	Allogeneic CD34-enriched peripheral blood stem cell transplantation in a patient with paroxysmal nocturnal haemoglobinuria 2003 ·Bone Marrow Transplantation ·Markus Ditschkowski,Rudolf Trenschel,(unknown),AH Elmaagacli,Dietrich W. Beelen	2
6	A comparison of chimerism and minimal residual disease between four different allogeneic transplantation methods in patients with chronic myelogenous leukemia in first chronic phase 2001 ·Bone Marrow Transplantation ·AH Elmaagacli,(unknown),Nina K. Steckel,Bertram Opalka,Rudolf Trenschel,S. Seeber,UW Schaefer,DW Beelen	27
7	The detection of wt-1 transcripts is not associated with an increased leukemic relapse rate in patients with acute leukemia after allogeneic bone marrow or peripheral blood stem cell transplantation 2000 ·Bone Marrow Transplantation ·AH Elmaagacli,DW Beelen,Rudolf Trenschel,UW Schaefer	33
8	The amount of BCR-ABL fusion transcripts detected by the real-time quantitative polymerase chain reaction method in patients with Philadelphia chromosome positive chronic myeloid leukemia correlates with the disease stage 2000 ·Annals of Hematology ·AH Elmaagacli,Dietrich W. Beelen,Bertram Opalka,S. Seeber,UW Schaefer	58
9	Biological effects of stroma-derived factor-1α on normal and CML CD34+ haemopoietic cells 2000 ·Leukemia ·Jan Dürig,C. Julian Rosenthal,AH Elmaagacli,C M Heyworth,(unknown),Christoph Kasper,J Novotný,Ulrich Dührsen	35
10	Reduced risk of persisting cytomegalovirus pp65 antigenemia and cytomegalovirus interstitial pneumonia following allogeneic PBSCT 2000 ·Bone Marrow Transplantation ·Rudolf Trenschel,(unknown),Johannes Hüsing,H. Ottinger,AH Elmaagacli,Michael Roggendorf,UW Schaefer,Volker Runde	46
11	Human herpesvirus 6 is an important pathogen in infectious lung disease after allogeneic bone marrow transplantation 2000 ·Bone Marrow Transplantation ·(unknown),AH Elmaagacli,UW Schaefer,Michael Roggendorf	39
12	Induction of a graft-versus-leukemia reaction by cyclosporin A withdrawal as immunotherapy for leukemia relapsing after allogeneic bone marrow transplantation 1999 ·Bone Marrow Transplantation ·AH Elmaagacli,DW Beelen,Guido Trenn,O. Schmidt,(unknown),UW Schaefer	53
13	Detection of CBFβ/MYH11 fusion transcripts in patients with inv(16) acute myeloid leukemia after allogeneic bone marrow or peripheral blood progenitor cell transplantation 1998 ·Bone Marrow Transplantation ·AH Elmaagacli,DW Beelen,Martin H. Kroll,(unknown),(unknown),UW Schaefer	47
14	A retrospective single centre study of the outcome of five different therapy approaches in 48 patients with relapse of chronic myelogenous leukemia after allogeneic bone marrow transplantation 1997 ·Bone Marrow Transplantation ·AH Elmaagacli,DW Beelen,UW Schaefer	15
15	Prolonged administration of interferon-alpha in patients with chronic- phase Philadelphia chromosome-positive chronic myelogenous leukemia before allogeneic bone marrow transplantation may adversely affect transplant outcome 1995 ·Blood ·DW Beelen,Ullrich Graeven,AH Elmaagacli,(unknown),O. Kloke,Bertram Opalka,UW Schaefer	88

About AH Elmaagacli

AH Elmaagacli is a scholar working on Hematology, Immunology and Allergy and Parasitology, having authored 15 papers that have together received 531 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (7 papers), Hematopoietic Stem Cell Transplantation (6 papers) and Chronic Myeloid Leukemia Treatments (6 papers). The work is most often cited by research in Hematology (413 citations), Genetics (156 citations) and Rheumatology (69 citations). AH Elmaagacli has collaborated with scholars based in Germany and United Kingdom. Frequent co-authors include UW Schaefer, DW Beelen, Rudolf Trenschel, Bertram Opalka, Dietrich W. Beelen, Michael Roggendorf, S. Seeber, Ullrich Graeven, O. Kloke and Michael Koldehoff. Their work appears in journals such as Blood, Leukemia and Haematologica.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact